ClinicalTrials.gg
CompletedNCT06259799Updated Nov 5, 2026

Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students

An interventional study of Smart Water Bottle in Dehydration, sponsored by Kennesaw State University. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Kennesaw State University · Not applicable, Interventional, and Prevention

Updated Nov 5, 2026Now CompletedStudy completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Approximately 60% of males and 40% of females do not meet current fluid intake recommendations, which is associated with adverse health consequences such as obesity, diabetes, and chronic kidney disease. Newer technologies have been designed to promote fluid intake. "Smart Water Bottles" use mHealth technology to capture fluid intake behaviors automatically and provide cues to encourage fluid consumption. Studies using Smart Water Bottles have helped some individuals increase fluid intake to help reduce kidney stone formation. However, limited research has assessed the efficacy of this technology on improving fluid intake in college students. College is a time with the potential to form healthy habits that carry into adulthood. Previous work has also identified daily changes in morning urine color, thirst perception, and body mass, as simple, inexpensive indicators of daily fluctuations in water balance. Tracking changes in these metrics has the potential to provide participants with evidence of adequate or inadequate fluid consumption. Thus, the combination of prompting from a smart water bottle, as well as daily self-monitoring changes in hydration status, may encourage college students to increase daily fluid consumption.

02

Conditions studied

  • Dehydration

Keywords

  • underhydration
  • copeptin
  • urine
  • water
03

In context

Dehydration

201 studies on the registry are indexed under Dehydration; 28 are open to participants now.

This study's enrollment of 30 is below the median of 43 across 145 interventional studies indexed under Dehydration.

Browse Dehydration studies →

Lead sponsor

Kennesaw State University is the lead sponsor of 9 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must report currently drinking less than the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (\<2.5 L per day for males; \<2.0 L per day for females).
  • Has access to a cell phone which can download the app associated with the Smart Water Bottle.

Exclusion criteria

Exclusion Criteria:

  • Currently trying to gain or lose weight
  • Have had surgery of the digestive tract
  • Currently taking diuretics (e.g., Thiazide, Loop diuretics or potassium-sparing diuretics)
  • Currently taking centrally-acting medications (e.g., anesthetics, anticonvulsants, central nervous system stimulants/amphetamines, muscle relaxants)
  • Report currently consuming at least the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (>= 2.5 L per day for males, >=2.0 L per day for females).
  • Currently pregnant (females)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Smart Water Bottle

    Participants in the intervention group will be prompted by the water bottle to drink (bottle will light up red) whenever they are behind on fluid intake recommendations for the day. The bottle will be linked to a smart phone application that participants will be instructed to download on their personal mobile device, but they will log into this device using a researcher provided username and password. The bottle will encourage male participants to consume 2.5 L and for female participants to consume 2.0 L of fluid. Participants will be asked to use this bottle to consume all water and enter any additional sources of fluid using the mobile application. The intervention group will also be asked to record their daily perceived thirst, first morning urine color, and body mass as a means of self-monitoring daily changes in hydration status, using a provided paper log.

    Behavioral: Smart Water Bottle

  • No intervention
    Control

    The control group will be asked to go about daily activities as normal. They will not receive the water bottle and will not be asked to track daily measures of thirst, morning urine color, or body mass.

Interventions

  • BehavioralSmart Water Bottle

    Participants in the intervention group will receive a bottle which measures participant fluid consumption. The bottle will be set to recommend 2.5L for male participants and 2.0L for female participants, consistent with fluid intake recommendations from the European Food Safety Authority for each sex. Participants will be prompted by the bottle (bottle will light up) when they are behind on fluid intake recommendations. Participants will use a validated urine color chart, 9 point Likert scale for thirst, and measure nude body mass on their own each morning. Participants will be informed that higher values for nude body mass and thirst, and lower values for nude body mass each morning may indicate they are less hydrated day-to-day.

06

What researchers measure

Primary outcomes

  1. Total Fluid Intake

    Total Fluid Intake will be reported by participants for 3 days before and after the intervention using a validated fluid log. The average of 3-days of fluid recording will be used.

    Time frame: Pre and Post 2-week intervention

  2. Changes in 24h urine osmolality

    Urinary osmolality reflects the concentration of urine, with higher values indicative of worse hydration. Urine osmolality will be collected for 3 days at the start and end of the study, with the average of each 3 day period used for analyses.

    Time frame: Pre and Post 2-week intervention

  3. Changes in 24h urine volume

    Higher urine volume tends to correspond with greater fluid intake.

    Time frame: Pre and Post 2-week intervention

Secondary outcomes

  1. Change in urine color measured by validated urine color chart

    A validated urine color will be used to rate urine samples. Higher values correspond with worse hydration.

    Time frame: Pre and Post 2-week intervention

  2. Changes in calorie intake from dietary log.

    The ASA-24 is an electronic diet log participants will use to record their diet at the start and end of the study.

    Time frame: Pre and Post 2-week intervention

  3. Change in copeptin

    Copeptin is a surrogate marker for vasopressin, a major fluid regulatory hormone which increases fluid conservation at the kidneys.

    Time frame: Pre and Post 2-week intervention

  4. Change in urine specific gravity

    Measures the density of the urine.

    Time frame: Pre and Post 2-week intervention

  5. Change in body water distribution

    Intracellular and extracellular water content measured via BIA.

    Time frame: Pre and Post 2-week intervention

  6. Change in Aldosterone

    Fluid regulatory hormone involved in plasma volume regulation.

    Time frame: Pre and Post 2-week intervention

  7. Hydration KAB Scales

    Brief questionnaire assessing hydration knowledge, attitudes, and beliefs about hydration and fluid intake behaviors.

    Time frame: Pre and Post 2-week intervention.

  8. Change in body fat percentage

    Assessed via dual-energy X-ray absorptiometry

    Time frame: Pre and Post 2-week intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Nov 5, 2026
Study completion
Apr 2026→Dec 16, 2025 (actual)
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Recruiting→Completed
    Study completion Apr 2026→Dec 16, 2025 (now actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06259799
Lead sponsor
Kennesaw State University
Responsible party
Sponsor
First posted
Feb 14, 2024
Start date
Apr 1, 2024
Primary completion
Dec 16, 2025
Completion
Dec 16, 2025
Last update
Nov 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion